M&A
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
Astellas
PR-M01-20-NI-006Jan 03, 2020
Patient Centricity
Astellas Takes Patient Centricity to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-19-NI-019Sep 20, 2019
License Agreement
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
Astellas
PR-M07-19-NI-055Jul 22, 2019
BLA
Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin
Astellas
PR-M07-19-NI-050Jul 19, 2019
Collaboration
Actinium Successfully Completes Second Module of Collaborative Research Program with Astellas; Third Module Initiated
Actinium Pharmaceuticals, Inc.
PR-M04-19-NI-011Apr 03, 2019
Collaboration
Actinium Pharma and Astellas Move to Third Phase of Their Collaboration
Nice Insight
PAO-M04-19-NI-006Apr 02, 2019
Launch
Astellas Launches PROGRAF® Granules (tacrolimus for oral suspension) in the U.S. for Pediatric Liver, Heart, and Kidney Transplant Patients
Astellas
PR-M03-19-NI-051Mar 19, 2019
Collaboration
Astellas and WiserCare Announce Collaboration to Improve Patient Experience
Astellas
PR-M02-19-NI-057Feb 26, 2019
Launch
Astellas Launches XOSPATA® (gilteritinib) in the U.S. for the Treatment of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) with a FLT3 Mutation
Astellas
PR-M12-18-NI-057Dec 17, 2018
Leukemia
Astellas Presents Updated Results from Phase 1 Study of Gilteritinib Plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Astellas
PR-M12-18-NI-025Dec 07, 2018
Launch
Astellas Global Health Foundation Launches
Astellas
PR-M11-18-NI-087-3340Nov 26, 2018
Acquisition
Quethera Acquired by Astellas Pharma
Emilie Branch
Pharma's Almanac
PAO-M08-18-NI-018Aug 14, 2018
FDA Approval
U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
Astellas
PR-M07-18-NI-047Jul 16, 2018
Appointment
Astellas names Nahrin Marino to Vice President, Head of Ethics & Compliance Americas
Astellas
PR-M06-18-NI-031Jun 11, 2018
Radio-Conjugates
Companies Join Forces to Develop Novel Radio-Conjugates
Nigel Walker
Nice Insight
PAO-M04-18-NI-002Apr 04, 2018
Strategic Partnership
Mitochondrial Expert Mitobridge Snapped Up by Astellas Pharma
Nice Insight
PAO-M01-18-NI-002Jan 02, 2018
Acquisition
Astellas Completes Acquisition of Ogeda
Guy Tiene
Nice Insight
PAO-M05-17-NI-026May 23, 2017